The involvement of many RTT-L-implicated genes in MECP2 function indicates that the replication of many of the clinical features of RTT-L like that of classical or atypical RTT could be attributed to the disruption of one of MECP2’s transcription regulatory activities. This evidence concerns the gene MECP2 and Rett syndrome.